ProQR Therapeutics N.V 20-F for FY2023
ProQR Therapeutics N.V. (PRQR)
20-F
2024-03-13
For: 2023-12-31
View Original
Added on
April 06, 2026
About this 20-F
ProQR Therapeutics N.V filed this 20-F on March 13, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 6.51M EUR
- up 81.2% from 3.59M EUR a year earlier
- Net loss
- 28.12M EUR
- compared with a net loss of 64.42M EUR a year earlier
- Diluted EPS
- -0.35 EUR
- compared with -0.90 EUR a year earlier